The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
The drug will be available to adults with mild cognitive impairments in the early stages of the disease. The company that ...
Eli Lilly's Kisunla secured standard approval from the U.S. Food and Drug Administration on Tuesday for slowing the ...
The Food and Drug Administration approved a new drug Tuesday that doctors said makes them optimistic about the future of the ...
A new Lilly drug is giving hope to the Alzheimer’s disease community. The drug, Kisunla — also known by the generic name ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...